Ozari vs Teladoc for GLP-1 Weight Loss: An Honest Comparison of Cost, Coverage, and Care

Sarah spent three weeks researching telehealth options for semaglutide before she realized the platform she'd almost chosen didn't actually offer the medication she needed. Her insurance wouldn't cover brand-name Wegovy, and the telehealth service only prescribed brand-name GLP-1s that cost $1,000+ monthly out of pocket. She's not alone. Thousands of patients ready to start GLP-1 therapy get stuck in this exact situation, confused by which telehealth platforms offer what medications, at what price, and with what level of ongoing support.

The telehealth landscape for weight loss medications has exploded over the past two years. With it comes real confusion about what you're actually getting when you sign up. Teladoc is a household name with broad telemedicine services. Ozari Health is a specialized GLP-1 provider focused exclusively on compounded semaglutide and tirzepatide. But the differences go far beyond brand recognition, and understanding them could save you hundreds of dollars monthly while getting you better results.

What You're Actually Paying For: Breaking Down the Real Costs

Let's cut through the marketing and talk numbers. Ozari Health offers compounded semaglutide and tirzepatide starting at $99 per month, with medication shipped directly to your door. That price includes your consultation, prescription, medication, and ongoing clinical support. There's no separate consultation fee, no hidden shipping charges, and no surprise upcharges when you need to adjust your dose.

Teladoc operates differently. Their weight management program, when available in your state, typically connects you with a provider who can prescribe weight loss medications. However, Teladoc primarily facilitates prescriptions for brand-name GLP-1 medications like Wegovy or Zepbound. You'll pay a consultation fee (usually $75-$99 per visit), then pay separately for your medication through your insurance or a pharmacy. If your insurance doesn't cover these brand-name drugs, you're looking at $1,000-$1,300 monthly at retail pharmacies.

Here's where it gets tricky: Teladoc doesn't consistently offer compounded GLP-1s across all states or through all providers in their network. We see patients come to us after spending weeks trying to get a Teladoc provider to prescribe compounded versions, only to be told they only write prescriptions for FDA-approved brand names. That's a fundamental business model difference, not a quality issue, but it matters enormously to your wallet.

The cost difference is staggering over time. A patient using brand-name Wegovy without insurance coverage pays roughly $15,600 annually. That same patient using compounded semaglutide through Ozari at $99 monthly pays $1,188 annually. Even if you need to move up to a higher-priced tier as your dose increases, you're still typically paying $200-300 monthly maximum, which is $2,400-3,600 annually. The math isn't even close.

Insurance coverage adds another layer. If your insurance covers brand-name GLP-1s for weight loss (many still don't), Teladoc can help you access them. But insurance coverage for weight loss medications remains inconsistent. According to recent data, only about 25% of commercial insurance plans cover GLP-1s for weight management without diabetes. That leaves three-quarters of patients paying out of pocket regardless of which platform they choose.

Medication Options and What's Actually Available

The type of medication you can access matters as much as the price. Ozari specializes in compounded semaglutide and tirzepatide, both available through state-licensed compounding pharmacies. These are the same active ingredients found in Wegovy and Zepbound, formulated by specialized pharmacies during the current shortage period under FDA guidance.

Compounded medications have gotten unfair criticism in some corners, so let's be clear about what they are. They're not generic versions or knockoffs. They're medications prepared by licensed U.S. pharmacies using the same active pharmaceutical ingredients as brand-name drugs. The FDA allows compounding of drugs on the shortage list, which currently includes semaglutide and tirzepatide. Compounding pharmacies must follow strict quality standards, and Ozari works exclusively with pharmacies that maintain the highest accreditation levels.

Clinical outcomes with compounded GLP-1s mirror what we see in the major trials. The STEP 1 trial showed patients on semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks. In our clinical experience with compounded semaglutide at Ozari, we're seeing comparable results. Patients who stay consistent with their medication and follow lifestyle recommendations typically lose 12-18% of their starting weight over similar timeframes.

Teladoc's medication options depend entirely on which provider you connect with and what they're comfortable prescribing. Some Teladoc providers will prescribe compounded GLP-1s. Others won't. You don't know until you're in the consultation, which you've already paid for. That inconsistency creates frustration for patients who've done their research and know they want compounded medication for cost reasons.

Tirzepatide availability is another differentiator. This dual GIP/GLP-1 receptor agonist showed even more impressive results in the SURMOUNT-1 trial, with patients losing an average of 20.9% body weight at the highest dose. Ozari offers compounded tirzepatide as a first-line option. Through Teladoc, you'd typically only access brand-name Zepbound, which faces the same insurance and cost barriers as Wegovy. For patients who don't respond as well to semaglutide or who want to try the medication with potentially stronger results, having affordable access to tirzepatide is huge.

The Patient Experience: Onboarding, Support, and Ongoing Care

Getting started with GLP-1 therapy should be straightforward, but the experience varies wildly between platforms. Ozari's onboarding is designed specifically for weight loss patients starting these medications. You complete a detailed health intake covering your medical history, current medications, weight loss history, and goals. A licensed provider reviews your information and determines if you're a candidate for GLP-1 therapy. If approved, your medication ships within days, and you receive detailed instructions on injection technique, dose escalation, and managing potential side effects.

The Teladoc experience depends on which service line you're accessing. Their general telemedicine platform connects you with available providers for various conditions. Weight management is one service among many. You'll schedule a video visit, discuss your weight loss goals, and the provider determines what they're willing to prescribe. The consultation itself is fine, but you're working with a generalist who sees everything from sinus infections to anxiety, not someone who spends their entire day managing GLP-1 patients.

That specialization matters more than you'd think. GLP-1 medications require careful dose titration. You start low and gradually increase to minimize side effects while maximizing weight loss. Providers who do this all day every day develop pattern recognition. They know that nausea in week two usually resolves with dietary adjustments. They know when constipation requires intervention versus when it's temporary. They know which patients benefit from slower titration and which can move faster.

Response time is another practical difference. Ozari's care team typically responds to patient questions within a few hours during business hours, often faster. You're not waiting days for guidance on whether your side effects are normal or concerning. With Teladoc, you'd need to schedule another consultation (and pay another fee) to discuss issues that come up between visits. For some patients, that barrier means suffering through manageable side effects unnecessarily or, worse, stopping medication that would've worked fine with minor adjustments.

Ongoing monitoring differs too. Ozari builds regular check-ins into the program as you increase doses. Your provider reviews your progress, side effects, and weight loss trajectory. Adjustments happen proactively based on how you're responding. Teladoc's model typically requires you to initiate follow-up visits yourself, which means more proactive work on your end to maintain continuity of care.

State Availability and Access Limitations

Not every telehealth platform operates in every state, and restrictions change frequently. Ozari Health currently serves patients in most U.S. states, with some exceptions based on state-specific telemedicine regulations. The best way to confirm availability is checking directly on their website with your state.

Teladoc has broader general telemedicine availability nationwide, but their weight management services aren't offered everywhere. Even in states where they operate, not all Teladoc providers are comfortable prescribing weight loss medications, especially newer GLP-1s. You might be in a state where Teladoc operates but still can't access the specific service you need.

Compounding pharmacy regulations add another variable. Some states have stricter requirements around compounded medications shipped from out of state. Both Ozari and Teladoc (when prescribing compounded options) must navigate these rules. The difference is that Ozari's entire business model depends on solving these logistics, so they've built robust pharmacy networks to ensure consistent access. Teladoc treats weight management as one service among dozens, so the infrastructure isn't as developed.

Prescription transfer is worth considering too. If you start with one platform and want to switch, can you? With brand-name medications prescribed through Teladoc, you could theoretically transfer your prescription to another provider or telehealth service. With compounded medications through Ozari, you'd need a new prescription from a new provider if you left, since compounded prescriptions are more specifically tied to the prescribing provider-pharmacy relationship. That said, if the service is working and affordable, the question becomes moot.

What Women Should Know

Women make up roughly 70% of GLP-1 patients for weight loss, and there are gender-specific considerations that matter when choosing a platform. Hormonal fluctuations affect both weight loss response and side effect profiles. Many women notice changes in appetite and GLP-1 effectiveness during different phases of their menstrual cycle. A provider experienced in managing female GLP-1 patients recognizes these patterns and doesn't prematurely adjust dosing based on one week's experience.

Pregnancy planning is critical. You need to stop GLP-1 medications at least two months before attempting conception. Ozari's intake process specifically addresses reproductive plans and builds this into your treatment timeline. We make sure women of childbearing age understand the importance of reliable contraception while on these medications. In our experience, specialized providers have these conversations proactively rather than as an afterthought.

Women also tend to experience nausea more intensely than men on GLP-1s, particularly in the first few weeks after dose increases. Having access to quick clinical guidance on managing this, from dietary timing to adjunctive treatments, makes the difference between pushing through successfully and giving up prematurely. The support infrastructure matters more for the demographic most likely to need it.

What Men Should Know

Men typically lose weight faster on GLP-1 medications than women, at least initially. That's largely due to higher starting muscle mass and metabolic rate. However, men are also more likely to lose muscle mass along with fat if they don't prioritize protein intake and resistance training. A GLP-1 program that emphasizes these lifestyle factors, not just medication, produces better body composition outcomes.

Men are statistically less likely to seek help for weight-related issues and more likely to wait until they've developed complications like prediabetes or hypertension. If you're already dealing with metabolic complications, the cardiovascular benefits of GLP-1s become especially relevant. The SELECT trial demonstrated that semaglutide reduced major cardiovascular events by 20% in patients with existing heart disease. That's not just weight loss; that's disease modification.

The convenience factor often matters more to men, who typically want efficient, no-nonsense healthcare. Getting medication delivered to your door every month without scheduling multiple video visits or driving to a pharmacy aligns better with how many men prefer to manage their health. Ozari's model of one platform handling everything removes friction that causes men to deprioritize their weight management.

From the Ozari Care Team

We recommend thinking beyond just the first month when you're comparing platforms. The real question isn't which service gets you started fastest, but which one supports you through the entire 12-18 month journey to your goal weight and then through maintenance. In our experience, patients succeed when they have consistent provider relationships, affordable ongoing access to medication, and responsive support when issues arise. That's what we've built at Ozari, and that's what keeps our patients on track month after month. The platform you choose should make staying on treatment easier than stopping.

Key Takeaways

• Ozari offers compounded semaglutide and tirzepatide starting at $99/month with all services included, while Teladoc charges separate consultation fees and typically prescribes brand-name medications costing $1,000+ monthly without insurance
• Compounded GLP-1s contain the same active ingredients as brand-name versions and produce comparable clinical results when prepared by accredited pharmacies
• Specialized GLP-1 platforms like Ozari provide provider consistency and faster response times compared to generalist telemedicine services that treat weight management as one offering among many
• Women should prioritize platforms with providers experienced in managing hormonal effects on GLP-1 response and side effects, plus clear reproductive health protocols
• The total cost over 12-18 months differs by more than $10,000 between affordable compounded options and brand-name medications without insurance coverage

Frequently Asked Questions

Can I use my insurance with Ozari or Teladoc for GLP-1 medications?

Teladoc can help you access insurance coverage if your plan covers brand-name GLP-1 medications like Wegovy or Zepbound for weight loss, though only about 25% of commercial plans currently do. Ozari focuses on compounded medications, which insurance typically doesn't cover, but the cash price starting at $99/month is usually far less than insurance copays for brand-name versions anyway. If you have insurance coverage for brand-name GLP-1s with a reasonable copay, Teladoc might facilitate that access. If you don't have coverage or face high copays, Ozari's compounded options are almost always more affordable.

Is compounded semaglutide as safe and effective as Wegovy?

Compounded semaglutide uses the same active pharmaceutical ingredient as Wegovy, prepared by licensed U.S. compounding pharmacies following strict quality standards. The FDA permits compounding of medications on shortage lists, which currently includes semaglutide. Clinical outcomes we see with compounded semaglutide mirror the results from major trials like STEP 1, where patients lost an average of 14.9% body weight. The key is ensuring your compounded medication comes from an accredited pharmacy, which Ozari guarantees by working exclusively with top-tier compounding facilities.

What happens if I need to talk to my provider between scheduled visits?

Ozari includes ongoing clinical support as part of your monthly fee, so you can message your care team with questions about side effects, dosing, or concerns without scheduling separate paid appointments. Response times are typically within hours during business days. With Teladoc's standard model, questions that arise between visits usually require scheduling another consultation at an additional cost, which creates a barrier to getting timely guidance. This difference matters especially during the first few months when you're adjusting to the medication and questions come up frequently.

Can I switch from Teladoc to Ozari or vice versa if I'm already on GLP-1 medication?

Yes, switching between platforms is possible, though the process differs depending on which direction you're going. If you're on brand-name medication through Teladoc and want to switch to compounded versions through Ozari for cost reasons, you'd simply start Ozari's intake process and let them know your current dose and experience. If you're on compounded medication through Ozari and want to switch to brand-name through Teladoc (perhaps because you gained insurance coverage), you'd schedule a Teladoc consultation and provide your medication history. There's no medical reason you can't switch, though you'll want to ensure continuity so you don't run out of medication during the transition.

How do I know which GLP-1 medication is right for me, semaglutide or tirzepatide?

Both medications are highly effective, with tirzepatide showing slightly better average weight loss in clinical trials (20.9% in SURMOUNT-1 versus 14.9% for semaglutide in STEP 1). Most providers start patients on semaglutide since we have more long-term safety data and it's been available longer. If you don't respond as well to semaglutide after giving it an adequate trial, or if you have specific metabolic factors that might respond better to tirzepatide's dual mechanism, switching makes sense. Ozari offers both options at comparable pricing, so the choice can be based on clinical factors rather than cost. Your provider will help determine which medication aligns best with your medical history and goals.

At Ozari Health, we offer compounded semaglutide and tirzepatide as low as $99/month, shipped to your door. Our specialized care team supports you through every step of your weight loss journey, from initial consultation through achieving and maintaining your goal weight. Learn more at ozarihealth.com.